Trafalgar International (GCAN) Payables (2016 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Payables of $7514.0 for Q1 2026, down 93.71% year-over-year from $119401.0 in Q1 2025, and down 11.75% quarter-over-quarter from $8514.0 in Q4 2025.
Trafalgar International (GCAN) Payables (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Payables history runs 11 years deep, the most recent figure standing at $7514.0 for Q1 2026.
- In Q1 2026, Payables fell 93.71% year-over-year to $7514.0; the TTM figure through Mar 2026 stood at $7514.0 (down 93.71% YoY), while the FY2025 annual figure was $8514.0, down 95.25% from the prior year.
- Payables for Q1 2026 stood at $7514.0, down from $8514.0 in the prior quarter.
- The five-year high for Payables was $480392.0 in Q1 2022, with the low at $7514.0 in Q1 2026.
- The 5-year median for Payables is $177855.0 (2024), against an average of $193510.5.
- The sharpest annual moves came in 2022 and 2025: Payables jumped 2734.84% in 2022, then slumped 95.25% in 2025.
- Greater Cannabis Company's Payables stood at $259688.0 in 2022, then slumped by 31.64% to $177531.0 in 2023, then advanced by 1.01% to $179316.0 in 2024, then plunged by 95.25% to $8514.0 in 2025, then decreased by 11.75% to $7514.0 in 2026.
- Business Quant data shows GCAN's Payables at $7514.0 in Q1 2026, $8514.0 in Q4 2025, and $22624.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 986.00 Mn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | 7,514.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,514.00 |
| Dec 31, 2025 | 8,514.00 |
| Sep 30, 2025 | 22,624.00 |
| Jun 30, 2025 | 20,950.00 |
| Mar 31, 2025 | 119,401.00 |
| Dec 31, 2024 | 179,316.00 |
| Sep 30, 2024 | 177,855.00 |
| Jun 30, 2024 | 176,696.00 |
| Mar 31, 2024 | 177,696.00 |
| Dec 31, 2023 | 177,531.00 |
| Sep 30, 2023 | 210,777.00 |
| Jun 30, 2023 | 248,777.00 |
| Mar 31, 2023 | 249,430.00 |
| Dec 31, 2022 | 259,688.00 |
| Sep 30, 2022 | 321,734.00 |
| Jun 30, 2022 | 450,783.00 |
| Mar 31, 2022 | 480,392.00 |
| Dec 31, 2021 | 380,800.00 |
| Sep 30, 2021 | 307,198.00 |
| Jun 30, 2021 | 196,219.00 |